research peptide combination designed to stimulate growth hormone release (GH)
through various mechanisms of action.
This blend combines CJC-1295 without DAC, a GHRH analog that supports the natural pulsation
of growth hormone, with Ipamorelin, a GHRP that acts on the
ghrelin receptor (GHSR) to create a synergistic effect. This peptide blend is produced according to high laboratory standards and verified via
High-Performance Liquid Chromatography (HPLC) to ensure a purity of ≥ 99 %.
The combination is intended solely for controlled endocrinological and biochemical research in vitro.
Contents of the blend
- CJC-1295 without DAC – 5 mg: Investigated for its role in the natural pulsation of growth hormone release via the GHRH receptor.
- Ipamorelin – 5 mg: Investigated for its selective stimulation of the ghrelin receptor without affecting cortisol or prolactin.
Important specifications
| Feature | Value / explanation |
|---|---|
| Name | CJC-1295 without DAC + Ipamorelin Blend |
| Total weight | 10 mg (5 mg CJC-1295 without DAC + 5 mg Ipamorelin) |
| Type | Combination of GHRH and GHRP analogs |
| Form | Lyophilisate (dry powder) |
| Purity | ≥ 99 % (HPLC tested) |
| Storage conditions | Store refrigerated, protected from light and moisture. |
Application & use (for research purposes only)
- Intended for in-vitro research purposes only.
- Not suitable for human or animal consumption or medical application.
- To be used for endocrine research on growth hormone regulation and ghrelin activation.
Specifications
| Concentration (mg) | 5+5mg |
| Bacteriostatic Water | 10ml, 3ml (included by default) |
| Insulin Needles | 10x 0.5ml insulin needles, 10x 1ml insulin needles, None |
| Alcohol Swabs | No, Yes |
Reviews
There are no reviews yet.